H. E. Bredkjaer

GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.

P. Humaidan, L. Westergaard, M. Bungum, 2005, Human reproduction.

Delivery rates after in-vitro fertilization following bilateral salpingectomy due to hydrosalpinges: a case control study.

Y. Zhou, A. Loft, S. Ziebe, 1999, Human reproduction.

Expression and characterization of preproVIP derived peptides in the human male urogenital tract

S. Krause, J. Fahrenkrug, B. Ottesen, 1995, Neuropeptides.

Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer.

T. Hansen, F. Nielsen, J. Christiansen, 2005, Reproduction.

VASOACTIVE INTESTINAL POLYPEPTIDE AND HUMAN VAGINAL BLOOD FLOW: COMPARISON BETWEEN TRANSVAGINAL AND INTRAVENOUS ADMINISTRATION

J. Fahrenkrug, B. Ottesen, C. Palle, 1990, Clinical and experimental pharmacology & physiology.

Individual versus standard dose of rFSH in a mild stimulation protocol for intrauterine insemination: a randomized study.

J. Bogstad, A. Pinborg, A. Loft, 2009, Human reproduction.

Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial.

P. Humaidan, G. Fried, S. Lindenberg, 2007, Human reproduction.

Vasoactive intestinal polypeptide loses its ability to increase vaginal blood flow after menopause.

J. Fahrenkrug, B. Ottesen, C. Palle, 1991, American journal of obstetrics and gynecology.

Predictors of ovarian response in intrauterine insemination patients and development of a dosage nomogram.

E. Budtz-Jørgensen, J. Bogstad, A. Pinborg, 2008, Reproductive biomedicine online.